Biophytis S.A. BPTS Stock
Biophytis S.A. Price Chart
Biophytis S.A. BPTS Financial and Trading Overview
Biophytis S.A. stock price | 8.22 USD |
Previous Close | 2.37 USD |
Open | 2.47 USD |
Bid | 0 USD x 4000 |
Ask | 0 USD x 1400 |
Day's Range | 2.32 - 2.66 USD |
52 Week Range | 2.26 - 14.4 USD |
Volume | 2.31K USD |
Avg. Volume | 15.86K USD |
Market Cap | 7.88M USD |
Beta (5Y Monthly) | 1.170498 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 150 USD |
BPTS Valuation Measures
Enterprise Value | 10.65M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -0.462 |
Trading Information
Biophytis S.A. Stock Price History
Beta (5Y Monthly) | 1.170498 |
52-Week Change | -73.59% |
S&P500 52-Week Change | 20.43% |
52 Week High | 14.4 USD |
52 Week Low | 2.26 USD |
50-Day Moving Average | 3.18 USD |
200-Day Moving Average | 4.77 USD |
BPTS Share Statistics
Avg. Volume (3 month) | 15.86K USD |
Avg. Daily Volume (10-Days) | 1.75K USD |
Shares Outstanding | 2.98M |
Float | 2.96M |
Short Ratio | 2.21 |
% Held by Insiders | 0% |
% Held by Institutions | 0.30% |
Shares Short | 40.44K |
Short % of Float | N/A |
Short % of Shares Outstanding | 1.29% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -51.15% |
Return on Equity (ttm) | -1244.39% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -23039000 USD |
Net Income Avi to Common (ttm) | -24216000 USD |
Diluted EPS (ttm) | -13.89 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 11.05M USD |
Total Cash Per Share (mrq) | 3.71 USD |
Total Debt (mrq) | 14.58M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.96 |
Book Value Per Share (mrq) | -0.8 |
Cash Flow Statement
Operating Cash Flow (ttm) | -18988000 USD |
Levered Free Cash Flow (ttm) | -10876000 USD |
Profile of Biophytis S.A.
Country | United States |
State | N/A |
City | Paris |
Address | Sorbonne University |
ZIP | 75005 |
Phone | 33 1 44 27 23 00 |
Website | https://www.biophytis.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 24 |
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.
Q&A For Biophytis S.A. Stock
What is a current BPTS stock price?
Biophytis S.A. BPTS stock price today per share is 8.22 USD.
How to purchase Biophytis S.A. stock?
You can buy BPTS shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biophytis S.A.?
The stock symbol or ticker of Biophytis S.A. is BPTS.
Which industry does the Biophytis S.A. company belong to?
The Biophytis S.A. industry is Biotechnology.
How many shares does Biophytis S.A. have in circulation?
The max supply of Biophytis S.A. shares is 317.35K.
What is Biophytis S.A. Price to Earnings Ratio (PE Ratio)?
Biophytis S.A. PE Ratio is 0.00000000 now.
What was Biophytis S.A. earnings per share over the trailing 12 months (TTM)?
Biophytis S.A. EPS is 0 USD over the trailing 12 months.
Which sector does the Biophytis S.A. company belong to?
The Biophytis S.A. sector is Healthcare.
Biophytis S.A. BPTS included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}